日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Relevance of Epstein-Barr Virus (EBV) miRNAs in EBV-Infected B Cells and B-Cell Lymphomas

EB病毒(EBV)miRNA在EBV感染的B细胞和B细胞淋巴瘤中的相关性

Rueda-Forero, Nohora Juliana; Kluiver, Joost; Koning, Marije; Berg, Anke van den; Diepstra, Arjan

Dynamics of circulating tumour DNA in relapsed/refractory diffuse large B-cell lymphoma patients

复发/难治性弥漫性大B细胞淋巴瘤患者循环肿瘤DNA的动态变化

Zhong, Yujie; Bult, Johanna; Veltmaat, Nick; de Jesus, Filipe Montes; Sillje, Laurens; Kluiver, Joost; van den Berg, Anke; Plattel, Wouter; Diepstra, Arjan; Nijland, Marcel

An integrative taxonomic approach reveals unexplored diversity in Croatian planarians

综合分类学方法揭示了克罗地亚涡虫未被探索的多样性

Vila-Farré, Miquel; Brand, Jeremias N; Boothe, Tobias; Brockmeyer, Maren; Ficze-Schmidt, Fruzsina; Grohme, Markus A; Weill, Uri; Kluiver, Kasper H; Gąsiorowski, Ludwik; Kauf, Lucija; Kanana, Yuliia; Bilandžija, Helena; Riutort, Marta; Rink, Jochen C

miRNA-dependent resistance mechanisms to anti-hormonal therapies in estrogen receptor-positive breast cancer patients

雌激素受体阳性乳腺癌患者中miRNA依赖性抗激素疗法耐药机制

Al Hashami, Zainab Salam; van der Vegt, Bert; Mourits, Marian J E; Kluiver, Joost; van den Berg, Anke

Molecular profiling of cell-free DNA from classic Hodgkin lymphoma patients identifies potential prognostic clusters and corresponds with disease dynamics

对经典霍奇金淋巴瘤患者游离DNA进行分子谱分析,可识别潜在的预后簇,并与疾病动态相对应。

Veltmaat, Nick; Tan, Geok-Wee; Zhong, Yujie; Teesink, Sophie; Terpstra, Martijn; Bult, Johanna; Nijland, Marcel; Kluiver, Joost; Diepstra, Arjan; van den Berg, Anke; Plattel, Wouter J

An Unexpected Finding of a PTPN11 Germline Mutation in a Patient With a Melanocytic Lesion With a Somatic MAP2K1 Mutation. Coincidence or Not?

在一名患有黑色素细胞病变并伴有体细胞MAP2K1突变的患者中,意外发现PTPN11种系突变。这究竟是巧合还是另有隐情?

van der Woude, Sven; Klein Wassink-Ruiter, J S; Kluiver, Joost; de Jonge, Marthe; Diercks, Gilles F H

Divergent WNT signaling and drug sensitivity profiles within hepatoblastoma tumors and organoids.

肝母细胞瘤肿瘤和类器官中 WNT 信号传导和药物敏感性特征的差异

Kluiver Thomas A, Lu Yuyan, Schubert Stephanie A, Kraaier Lianne J, Ringnalda Femke, Lijnzaad Philip, DeMartino Jeff, Megchelenbrink Wouter L, Amo-Addae Vicky, Eising Selma, de Faria Flavia W, Münter Daniel, van de Wetering Marc, Kerl Kornelius, Duiker Evelien, van den Heuvel Marius C, de Meijer Vincent E, de Kleine Ruben H, Molenaar Jan J, Margaritis Thanasis, Stunnenberg Hendrik G, de Krijger Ronald R, Zsiros József, Clevers Hans, Peng Weng Chuan

Extracellular vesicle-mediated delivery of CRISPR/Cas9 ribonucleoprotein complex targeting proprotein convertase subtilisin-kexin type 9 (Pcsk9) in primary mouse hepatocytes

利用细胞外囊泡介导的 CRISPR/Cas9 核糖核蛋白复合物靶向原代小鼠肝细胞中的前蛋白转化酶枯草杆菌蛋白酶-kexin 9 型 (Pcsk9)

Nazma F Ilahibaks,Thomas A Kluiver,Olivier G de Jong,Saskia C A de Jager,Raymond M Schiffelers,Pieter Vader,Weng Chuan Peng,Zhiyong Lei,Joost P G Sluijter

Targeting pediatric cancers via T-cell recognition of the monomorphic MHC class I-related protein MR1

通过 T 细胞识别单态 MHC I 类相关蛋白 MR1 来靶向治疗儿童癌症

Annelisa M Cornel, Loutje van der Sman, Jip T van Dinter, Marta Arrabito, Ester Dunnebach, Marliek van Hoesel, Thomas A Kluiver, Ana P Lopes, Noël M M Dautzenberg, Linde Dekker, Jorik M van Rijn, Denise A M H van den Beemt, Juliane L Buhl, Aimee du Chatinier, Farnaz Barneh, Yuyan Lu, Luca Lo Nigro, 

Molecular Tumor Board of the University Medical Center Groningen (UMCG-MTB): outcome of patients with rare or complex mutational profiles receiving MTB-advised targeted therapy

格罗宁根大学医学中心分子肿瘤委员会 (UMCG-MTB):接受 MTB 建议的靶向治疗的具有罕见或复杂突变谱的患者的预后

de Jager, V D; Plomp, P; Paats, M S; van Helvert, S; Elst, A Ter; van den Berg, A; Dubbink, H J; van Geffen, W H; Zhang, L; Hendriks, L E L; Hiltermann, T J N; Hiddinga, B I; Hijmering-Kappelle, L B M; Jalving, M; Kluiver, J; Koopman, B; van Kruchten, M; van der Logt, E M J; Piet, B; van Putten, J; Reitsma, B H; Rutgers, S R; de Vries, M; Stigt, J A; Groves, M R; Timens, W; Willems, S M; van Kempen, L C; Schuuring, E; van der Wekken, A J